MAE-WEST RSC - Eicosanoids Profiling Core
MAE-WEST RSC - Eicosanoids Profiling Core
批准号:
10198759
负责人:
Mohit Jain
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
关键词:
AcidsAgeAgingAlzheimer&aposs disease related dementiaAnimal ModelAnimalsAnti-Inflammatory AgentsArachidonic AcidsBasic ScienceBioinformaticsBiologicalBiological AgingBiological AssayBiological ProcessBiometryBlood CirculationBlood VesselsBrainCardiologyCenters of Research ExcellenceChronicChronic Kidney FailureChronologyClinical ResearchComplexCore FacilityDataDevelopmentDiseaseEFRACEicosanoidsEicosapentaenoic AcidElderlyEndothelial CellsEndotheliumEnsureEpidemiologistEquilibriumEvaluationExhibitsFailureFamilyFemaleFoundationsFunctional disorderFundingGenerationsGeriatricsGoalsGonadal Steroid HormonesGrantHeart failureHumanIndividualInflammationInflammatoryInflammatory ResponseInfrastructureLife Cycle StagesLipidsLongevityMass Spectrum AnalysisMeasuresMediator of activation proteinMetabolic syndromeMethodologyMethodsMicrovascular DysfunctionMolecularMorbidity - disease rateNatureNephrologyObesityOrganOrganization and AdministrationPhysiologicalPilot ProjectsPlasmaPlayPolyunsaturated Fatty AcidsPopulation StudyPublic HealthRenal functionReproducibilityRequest for ApplicationsResearch MethodologyResearch PersonnelResolutionResource SharingResourcesRiskRoleSamplingScientific Advances and AccomplishmentsScientistServicesSex DifferencesSpecialized CenterStandardizationStressStructureSystemTNF geneTimeTrainingVariantWomanWorkadvanced analyticsage effectage relatedburden of illnesscareerclinical developmentcohortcomputational chemistrycytokinedata handlingdata standardseffective interventionexperiencefrailtygamma-Linolenic Acidheart functionhigh dimensionalityimprovedin vivoindexinginflammatory markerinsightliquid chromatography mass spectrometrymalemenmicrovascular agingnovelpreservationprospectiveresponsesexsex disparitysexual dimorphismstressorsystemic inflammatory responsetooltranslational scientist
中文摘要
项目摘要- MAE-WEST SCORE类花生酸分析核心
在生命过程中,慢性应激源导致多器官衰老和功能障碍,最终,
临床疾病的发展。性仍然是衰老的性质和速度的关键决定因素,
中心blog在哺乳动物物种中,更明显的是,雌性的衰老与雌性的衰老根本不同。
男性。随着人类生理年龄的增长,女性和男性之间的生物衰老差异
变得更加明显,最终在女性占主导地位的一些重要的病态
疾病状况,尤其包括阿尔茨海默病和相关痴呆(ADRD)、心力衰竭伴
射血分数保留(HFpEF)、进行性慢性肾病(CKD),进而全身虚弱。
这些主要发病率女性占优势的机制仍然未知,
这可以用性激素的变化或生存偏差来解释。我们的初步工作支持一个中心假设,
炎症性类花生酸介质的性别二型性导致微血管
功能障碍,反过来,与年龄相关的多器官疾病的性别差异,包括ADRD,HFpEF和
CKD。阐明ADRD、HFpEF和CKD女性优势的共同病理生理学基础
是采取有效干预措施减少妇女年龄相关疾病过度负担的关键。我们
建议建立微血管老化和类花生酸-妇女的评价系统老化韧性
(美西)(“你永远不会太老,变得年轻!”)卓越研究专业中心
(评分)性别差异,响应NIH RFA-OD-19-013。我们的目标是形成一个强大的和可持续的
学术活动的结构集中在系统地询问关系中的性别差异
在类花生酸、微血管功能障碍和年龄相关的终末器官疾病中,
微血管老化对大脑、心脏和肾脏功能的影响。这一目标将通过一个杰出的
临床医生-科学家协作团队(具有老年病学、心脏病学和肾脏病学专业知识),
流行病学家、基础和转化科学家、分析化学家、生物统计学家和生物信息学家。
利用我们的集体经验、资源和基础设施,我们将推进科学事业
通过3个基础项目协调一致,互补但独立。我们将建立一个专门的
资源支持核心-一个将被有意创建为独立的类花生酸分析核心(EPC)
在更大的MAE-WEST评分范围内。这种组织特征不仅可以最大限度地利用资源,
在项目目标之间共享,但也确保能够单独和独立地增强
对早期职业调查员进行方法培训,重要的是,及时为
实习生试点项目。EPC的专门努力将允许有效地生成初步数据,
为早期职业和核心活动获得额外和辅助赠款资金,这将额外
有助于整个MAE-WEST SCORE的长期可持续性。
英文摘要
Project Abstract – MAE-WEST SCORE Eicosanoids Profiling Core
Over the course of life, chronic stressors contribute to multi-organ aging and dysfunction and, ultimately, the
development of clinical disease. Sex remains a critical determinant of the nature and pace of aging and ultimately
longevity. Among mammalian species, it is even more clear that females fundamentally age differently from
males. With advancing chronologic age in humans, differences in biological aging between women and men
become even more pronounced, culminating in the female predominance for a number of important morbid
disease conditions, including notably Alzheimer’s disease and related dementias (ADRD), heart failure with
preserved ejection fraction (HFpEF), progressive chronic kidney disease (CKD), and in turn systemic frailty.
Mechanisms underlying the female predominance for these major morbidities remains unknown and are not
explained by variations in sex hormones or survival bias. Our preliminary work supports a central hypothesis that
sexual dimorphism in inflammatory eicosanoid mediators contribute to sex differences in microvascular
dysfunction and, in turn, to sex differences in age-related multi-organ disease, including for ADRD, HFpEF and
CKD. Elucidating a common pathophysiologic basis for the female predominance of ADRD, HFpEF, and CKD
holds the key to effective interventions for reducing the excess burden of age-related disease in women. We
propose to establish the Microvascular Aging and Eicosanoids – Women’s Evaluation of Systemic aging Tenacity
(MAE-WEST) (“You are never too old to become younger!”) Specialized Center of Research Excellence
(SCORE) on Sex Differences, in response to NIH RFA-OD-19-013. Our goal is to form a robust and sustainable
structure of academic activities centered on systematically interrogating sex differences in the relationship
among eicosanoids, microvascular dysfunction, and age-related end-organ disease, with an initial focus on the
microvascular aging effects on brain, heart, and kidney function. This goal will be achieved by an outstanding
collaborative team of clinician-scientists (with expertise in geriatrics, cardiology, and nephrology),
epidemiologists, basic and translational scientists, analytical chemists, biostatisticians, and bioinformaticians.
Leveraging our collective experience, resources, and infrastructure, we will advance the scientific enterprise
through 3 foundational projects aligned and complementary yet independent. We will establish a dedicated
Resource Support Core - an Eicosanoids Profiling Core (EPC) that will be intentionally created as standalone
organization within the larger MAE-WEST SCORE. This organizational feature will not only maximize resource
sharing across the project aims but also ensure the ability to separately and independently augment the
methodological training of early career investigators and, importantly, timely provision of in-kind services for
trainee pilot projects. The dedicated effort of the EPC will allow efficient generation of preliminary data for
acquiring additional and ancillary grant funding for both early career and core activities, which will additionally
contribute to the long-term sustainability of the MAE-WEST SCORE as a whole.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
-
批准号:10447679
-
项目类别:
-
资助金额:$70.64万
-
财政年份:2021
-
负责人:Mohit Jain
-
依托单位:
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
-
批准号:10318063
-
项目类别:
-
资助金额:$78.34万
-
财政年份:2021
-
负责人:Mohit Jain
-
依托单位:
MAE-WEST RSC - Eicosanoids Profiling Core
-
批准号:10450759
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2020
-
负责人:Mohit Jain
-
依托单位:
Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease
-
批准号:9233700
-
项目类别:
-
资助金额:$57.73万
-
财政年份:2017
-
负责人:Mohit Jain
-
依托单位:
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy
-
批准号:9329477
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2016
-
负责人:Mohit Jain
-
依托单位:
Reactive electrophiles in human aging and longevity
-
批准号:9162248
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2016
-
负责人:Mohit Jain
-
依托单位:
Mapping metabolic activities in stem cell-derived models of human cardiomyopathy
-
批准号:9170227
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2016
-
负责人:Mohit Jain
-
依托单位:
Reactive electrophiles in human aging and longevity
-
批准号:9323237
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2016
-
负责人:Mohit Jain
-
依托单位:
RapidFire mass spectrometry system
-
批准号:8826541
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2015
-
负责人:Mohit Jain
-
依托单位:
A systems approach to metabolic dysregulation in the heart
-
批准号:8260396
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2011
-
负责人:Mohit Jain
-
依托单位:
A systems approach to metabolic dysregulation in the heart
-
批准号:8768529
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2011
-
负责人:Mohit Jain
-
依托单位:
A systems approach to metabolic dysregulation in the heart
-
批准号:8448190
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2011
-
负责人:Mohit Jain
-
依托单位:
A systems approach to metabolic dysregulation in the heart
-
批准号:8091022
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2011
-
负责人:Mohit Jain
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: